Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET

Tumor Metabolism of Lung Cancer Underwent Percutaneous Radiation Measured With F-18-FDG-PET

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00180154

Enrollment

Registered

2005-09-16

Start date

2005-07-31

Completion date

Unknown

Last updated

2011-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

radiation therapy, F-18-FDG, NSCLC

Brief summary

The purpose of the study is to describe the regional and global FDG-kinetics in non-small-cell lung cancer (NSCLC) during percutaneous radiation therapy.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Histologically confirmed NSCLC not curable by surgery * Karnofsky \> 80% * Tumor volume and localization allow curative radiotherapy * Written consent

Exclusion criteria

* Metastases * Diabetes * Pregnancy * Psychiatric impairment

Countries

Germany

Outcome results